Issue 26, 2023, Issue in Progress

Adsorption of Favipiravir on pristine graphene nanosheets as a drug delivery system: a DFT study


The efficiency of pristine graphene (GN) in the delivery process of the Favipiravir (FPV) anti-COVID-19 drug was herein revealed within the FPV⋯GN complexes in perpendicular and parallel configurations in terms of the density functional theory (DFT) method. Adsorption energy findings unveiled that the parallel configuration of FPV⋯GN complexes showed higher desirability than the perpendicular one, giving adsorption energy up to −15.95 kcal mol−1. This favorability could be interpreted as a consequence of the contribution of π–π stacking to the overall strength of the adsorption process in the parallel configuration. Frontier molecular orbitals (FMO) findings demonstrated the ability of the GN nanosheet to adsorb the FPV drug by the alteration in the EHOMO, ELUMO, and Egap values before and after the adsorption process. Based on Bader charge results, the FPV drug and GN sheet exhibited electron-donating and -accepting characters, respectively, which was confirmed by the negative sign of the computed charge transfer (Qt) values. The FPV(R)⋯T@GN complex showed the most desirable Qt value of −0.0377e, which was in synoptic with the adsorption energy pattern. Electronic properties of GN were also altered after the adsorption of the FPV drug in both configurations, with more observable changes in the parallel one. Interestingly, the Dirac point of the GN sheet coincided with the Fermi level after the adsorption process, indicating that the adsorption process unaffected the presence of the Dirac point. The occurrence of the adsorption process was also noticed by the existence of new bands and peaks in the band structure and DOS plots, respectively. Short recovery time rendered the GN nanosheet an efficient FPV drug delivery system. The obtained findings provide new insight into the biomedical applications of the GN sheet as a promising drug delivery system.

Graphical abstract: Adsorption of Favipiravir on pristine graphene nanosheets as a drug delivery system: a DFT study

Supplementary files

Article information

Article type
15 May 2023
29 May 2023
First published
09 Jun 2023
This article is Open Access
Creative Commons BY license

RSC Adv., 2023,13, 17465-17475

Adsorption of Favipiravir on pristine graphene nanosheets as a drug delivery system: a DFT study

M. A. A. Ibrahim, M. H. A. Hamad, A. H. M. Mahmoud, G. A. H. Mekhemer, P. A. Sidhom, S. R. M. Sayed, N. A. M. Moussa, A. I. M. Rabee, E. Dabbish and T. Shoeib, RSC Adv., 2023, 13, 17465 DOI: 10.1039/D3RA03227B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity